|Biotech Due Diligence||
A round-up of all the biotech news dumped Friday night while you were heading off for Memorial Day weekend festivities!
Product development updates from Medtronic and Boston Scientific, and price control decisions from India that could change device manufacturers' emerging market strategy.
Enjoy a new collection of tweets highlighting the latest scientific and medical papers driving the conversation.
Earnings updates, acquisition progress, and regulatory strategy in this week's reading list!
Your support is greatly appreciated